The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations.


Autoria(s): Gaughan, D.J.; Kluijtmans, L.A.J.; Barbaux, S.; McMaster, D.; Young, Ian; Yarnell, John; Evans, Alun; Whitehead, A.S.
Data(s)

2001

Identificador

http://pure.qub.ac.uk/portal/en/publications/the-methionine-synthase-reductase-mtrr-a66g-polymorphism-is-a-novel-genetic-determinant-of-plasma-homocysteine-concentrations(6ba778fb-8759-4e54-acef-6a0f53a3d37d).html

http://www.scopus.com/inward/record.url?scp=0034904708&partnerID=8YFLogxK

Idioma(s)

eng

Direitos

info:eu-repo/semantics/restrictedAccess

Fonte

Gaughan , D J , Kluijtmans , L A J , Barbaux , S , McMaster , D , Young , I , Yarnell , J , Evans , A & Whitehead , A S 2001 , ' The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations. ' Atherosclerosis , vol 157 , no. 2 , pp. 451-456 .

Palavras-Chave #/dk/atira/pure/subjectarea/asjc/2700/2705 #Cardiology and Cardiovascular Medicine
Tipo

article